Answers are grounded in this paper and cite their sources.
Ultra-high-pressure liquid chromatography (UPLC) is used for drug analysis in the pharmaceutical industry. Short turnaround time, method reliability, method sensitivity is the some of advantages of using UPLC. Sugammadex is a molecule that is modified cyclodextrin newly treatment for reversal neuromuscular blocking agent. This study aimed to develop and validate a new method, using UPLC to perform a quantitative analysis of Sugammadex related substances in the drug product. The separation in the described chromatographic system was accomplished using a mobile phase consisting of a mixture of phosphate buffer and acetonitrile and a UPLC BEH C8 column (50 x 2.1mm, 1.7m) with gradient elution on a consistent flow rate of 0.4mL/min. PDA detection was carried out at a wavelength of 210nm. In line with The International Conference on Harmonization (ICH) guidelines the drug was exposed to various forced degradation conditions, including photolysis, oxidation, thermal degradation and hydrolysis under acidic, basic and neutral conditions. The linearity varied in the range from 0.9g/mL to 11.0g/mL for Sugammadex. The ranges of the detection and quantitation limits were determined to be 0.3g/mL and 0.9g/mL respectively for Sugammadex. The calculated correlation coefficients were found out to be higher than 0.999. The RSD values for repeatability and intermediate precision were determined to be lower than 2%. For all degration products of interest, the average recovery values were determined within the range of 95.00%-105.00%. We conclude that this newly developed analytical procedure applies to the quality control of drug product.
No takes yet. Share an insight, caveat, or question.
Kadir Aluc (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: